AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| QMS | Ann: Change of Director's Interest Notice | 24/04/18 | 0 | 13 | |||
|
|||||||
| QMS | Ann: Change of Director's Interest Notice | 24/04/18 | 0 | 14 | |||
|
|||||||
| QMS | Ann: Appendix 3B | 24/04/18 | 0 | 14 | |||
|
|||||||
| QMS | Ann: Becoming a substantial holder from MUFG | 20/04/18 | 0 | 49 | |||
|
|||||||
| QMS | Ann: Becoming a substantial holder from MS | 20/04/18 | 0 | 50 | |||
|
|||||||
| QMS | Ann: Ceasing to be a substantial holder from MUFG | 11/04/18 | 0 | 49 | |||
|
|||||||
| QMS | Ann: Ceasing to be a substantial holder from MS | 10/04/18 | 0 | 62 | |||
|
|||||||
| QMS | Ann: Becoming a substantial holder from MUFG | 10/04/18 | 0 | 50 | |||
|
|||||||
See All Discussions
ASX News